Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus

Radiographics

Volumn 31, Issue 1, 2011, Pages 5-30

  Hegde, Amogh N ^a,d   Mohan, Suyash ^c   Lath, Narayan ^a,b   Lim, C C Tchoyoson ^d  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL GANGLION; BRAIN DISEASE; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTOXICATION; LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; THALAMUS; WILSON DISEASE;

BASAL GANGLIA; BRAIN DISEASES; DIAGNOSIS, DIFFERENTIAL; HEPATOLENTICULAR DEGENERATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; POISONING; THALAMUS;

EID: 79953787277     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.311105041     Document Type: Article

References (75)

1. Kretschmann HJ, Weinrich W. Neurofunctional systems. In: Kretschmann HJ, Weinrich W, eds. Cranial neuroimaging and clinical neuroanatomy: atlas of MR imaging and computed tomography. 3rd ed. New York, NY: Thieme, 2003; 383-387.
2. Heier LA, Bauer CJ, Schwartz L, Zimmerman RD, Morgello S, Deck MD. Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol 1989;10(5):929-936.
3. Bennett JC, Maffly RH, Steinbach HL. The significance of bilateral basal ganglia calcification. Radiology 1959;72(3):368-378.
4. Milton WJ, Atlas SW, Lexa FJ, Mozley PD, Gur RE. Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. Radiology 1991;181(3):715-719.
5. Finelli PF, DiMario FJ Jr. Diagnostic approach in patients with symmetric imaging lesions of the deep gray nuclei. Neurologist 2003;9(5):250-261.
6. Schmahmann JD. Vascular syndromes of the thalamus. Stroke 2003;34(9):2264-2278.
7. Osborn A. Diagnostic neuroradiology. St Louis, Mo: Mosby, 1994; 341-363.
8. Kretschmann HJ, Weinrich W. Topography of the neurocranium and its intracranial spaces and structures in multiplanar parallel slices. In: Kretschmann HJ, Weinrich W, eds. Cranial neuroimaging and clinical neuroanatomy: magnetic resonance imaging and computed tomography. 2nd ed. New York, NY: Thieme, 1992; 173-253.
9. Rachinger J, Fellner FA, Stieglbauer K, Trenkler J. MR changes after acute cyanide intoxication. AJNR Am J Neuroradiol 2002;23(8):1398-1401.
10. Ghio AJ, Stonehuerner JG, Dailey LA, et al. Carbon monoxide reversibly alters iron homeostasis and respiratory epithelial cell function. Am J Respir Cell Mol Biol 2008;38 (6):715-723.
11. O'Donnell P, Buxton PJ, Pitkin A, Jarvis LJ. The magnetic resonance imaging appearances of the brain in acute carbon monoxide poisoning. Clin Radiol 2000;55(4): 273-280.
12. Pujol A, Pujol J, Graus F, et al. Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993;43(1):65-69.
13. Naegele T, Grodd W, Viebahn R, et al. MR imaging and (1) H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000;216 (3):683-691.
14. Wong YC, Au WL, Xu MS, Ye J, Lim CC. Magnetic resonance spectroscopy in adult-onset citrullinemia: elevated glutamine levels in comatose patients. Arch Neurol 2007; 64(7):1034-1037.
15. Takanashi J, Barkovich AJ, Cheng SF, Kostiner D, Baker JC, Packman S. Brain MR imaging in acute hyperammonemic encephalopathy arising from late-onset ornithine transcarbamylase deficiency. AJNR Am J Neuroradiol 2003;24(3):390-393.
16. Takanashi J, Barkovich AJ, Cheng SF, et al. Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol 2003;24(6): 1184-1187.
17. Lai PH, Tien RD, Chang MH, et al. Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR Am J Neuroradiol 1996; 17(6):1057-1064.
18. Lee EJ, Choi JY, Lee SH, Song SY, Lee YS. Hemichoreahemiballism in primary diabetic patients: MR correlation. J Comput Assist Tomogr 2002;26 (6):905-911.
19. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol 1985;17(5): 421-430.
20. Kao SL, Chan CL, Tan B, et al. An unusual outbreak of hypoglycemia. N Engl J Med 2009;360(7): 734-736.
21. Lim CC, Gan R, Chan CL, et al. Severe hypoglycemia associated with an illegal sexual enhancement product adulterated with glibenclamide: MR imaging findings. Radiology 2009;250(1):193-201.
22. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y. Specific changes in human brain after hypoglycemic injury. Stroke 1997;28(3): 584-587.
23. Aoki T, Sato T, Hasegawa K, Ishizaki R, Saiki M. Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology 2004;63(2): 392-393.
24. Hasegawa Y, Formato JE, Latour LL, et al. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke 1996;27(9):1648-1655; discussion 1655-1656.
25. Huang BY, Castillo M. Hypoxic-ischemic brain injury: imaging findings from birth to adulthood. RadioGraphics 2008;28(2):417-439.
26. Kjos BO, Brant-Zawadzki M, Young RG. Early CT findings of global central nervous system hypoperfusion. AJR Am J Roentgenol 1983;141(6): 1227-1232.
27. Bird CR, Drayer BP, Gilles FH. Pathophysiology of "reverse" edema in global cerebral ischemia. AJNR Am J Neuroradiol 1989;10(1):95-98.
28. Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998;19(2): 369-377.
29. Detre JA, Wang ZY, Bogdan AR, et al. Regional variation in brain lactate in Leigh syndrome by localized 1H magnetic resonance spectroscopy. Ann Neurol 1991;29(2): 218-221.
30. King AD, Walshe JM, Kendall BE, et al. Cranial MR imaging in Wilson's disease. AJR Am J Roentgenol 1996;167(6): 1579-1584.
31. Sener RN. Diffusion MR imaging changes associated with Wilson disease. AJNR Am J Neuroradiol 2003;24(5): 965-967.
32. Kishibayashi J, Segawa F, Kamada K, Sunohara N. Study of diffusion weighted magnetic resonance imaging in Wilson's disease [in Japanese]. Rinsho Shinkeigaku 1993;33 (10):1086-1089.
33. Lampl C, Yazdi K. Central pontine myelinolysis. Eur Neurol 2002;47(1):3-10.
34. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 1959;81(2):154-172.
35. Miller GM, Baker HL Jr, Okazaki H, Whisnant JP. Central pontine myelinolysis and its imitators: MR findings. Radiology 1988;168(3):795-802.
36. Ogershok PR, Rahman A, Nestor S, Brick J. Wernicke encephalopathy in nonalcoholic patients. Am J Med Sci 2002;323(2):107-111.
37. Zuccoli G, Gallucci M, Capellades J, et al. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients. AJNR Am J Neuroradiol 2007;28(7):1328-1331.
38. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348(1): 33-40.
39. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28(4):345-349.
40. Savoiardo M, Halliday WC, Nardocci N, et al. Hallervorden-Spatz disease: MR and pathologic findings. AJNR Am J Neuroradiol 1993;14(1): 155-162.
41. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996;53(9):913-920.
42. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996;53(2):162-166.
43. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43(1):32-40.
44. Kandiah N, Tan K, Pan AB, et al. Creutzfeldt-Jakob disease: which diffusion-weighted imaging abnormality is associated with periodic EEG complexes? J Neurol 2008;255 (9):1411-1414.
45. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000;355(9213): 1412-1418. [Published correction appears in Lancet 2000;356(9224):170.]
46. Tschampa HJ, Mürtz P, Flacke S, Paus S, Schild HH, Urbach H. Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 2003;24(5): 908-915.
47. Avrahami E, Cohn DF, Feibel M, Tadmor R. MRI demonstration and CT correlation of the brain in patients with idiopathic intracerebral calcification. J Neurol 1994;241 (6):381-384.
48. Smith AB, Smirniotopoulos JG, Rushing EJ, Goldstein SJ. Bilateral thalamic lesions. AJR Am J Roentgenol 2009;192 (2):W53-W62.
49. Spearman MP, Jungreis CA, Wehner JJ, Gerszten PC, Welch WC. Endovascular thrombolysis in deep cerebral venous thrombosis. AJNR Am J Neuroradiol 1997;18(3): 502-506.
50. Lim CC. Magnetic resonance imaging findings in bilateral basal ganglia lesions. Ann Acad Med Singapore 2009;38 (9):795-798.
51. Forbes KP, Pipe JG, Heiserman JE. Evidence for cytotoxic edema in the pathogenesis of cerebral venous infarction. AJNR Am J Neuroradiol 2001;22(3): 450-455.
52. Crawford SC, Digre KB, Palmer CA, Bell DA, Osborn AG. Thrombosis of the deep venous drainage of the brain in adults: analysis of seven cases with review of the literature. Arch Neurol 1995;52(11): 1101-1108.
53. Castaigne P, Lhermitte F, Buge A, Escourolle R, Hauw JJ, Lyon-Caen O. Paramedian thalamic and midbrain infarcts: clinical and neuropathological study. Ann Neurol 1981;10(2):127-148.
54. Kostanian V, Cramer SC. Artery of Percheron thrombolysis. AJNR Am J Neuroradiol 2007;28(5): 870-871.
55. Percheron G. The anatomy of the arterial supply of the human thalamus and its use for the interpretation of the thalamic vascular pathology. Z Neurol 1973;205(1):1-13.
56. Lasjaunias P, Berenstein A, Brugge KGT, eds. Surgical neuroangiography. 2nd ed. Vol 1. Berlin, Germany: Springer-Verlag, 2000;526-562.
57. Matheus MG, Castillo M. Imaging of acute bilateral paramedian thalamic and mesencephalic infarcts. AJNR Am J Neuroradiol 2003;24(10):2005-2008.
58. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341(17):1284-1291.
59. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 1999;122(pt 11):2171-2182.
60. Hadfield MG, Aydin F, Lippman HR, Sanders KM. Neuro-Behçet's disease. Clin Neuropathol 1997;16(2): 55-60.
61. Rosas H, Wippold FJ 2nd. West Nile virus: case report with MR imaging findings. AJNR Am J Neuroradiol 2003;24 (7):1376-1378.
62. Einsiedel L, Kat E, Ravindran J, Slavotinek J, Gordon DL. MR findings in Murray Valley encephalitis. AJNR Am J Neuroradiol 2003;24(7):1379-1382.
63. Kumar S, Misra UK, Kalita J, Salwani V, Gupta RK, Gujral R. MRI in Japanese encephalitis. Neuroradiology 1997;39 (3):180-184.
64. Prakash M, Kumar S, Gupta RK. Diffusion-weighted MR imaging in Japanese encephalitis. J Comput Assist Tomogr 2004;28(6):756-761.
65. Colombo FA, Vidal JE, Penalva de Oliveira AC, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol 2005;43 (10):5044-5047.
66. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986;19(3):224-238.
67. Dina TS. Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 1991;179(3): 823-828.
68. Erdag N, Bhorade RM, Alberico RA, Yousuf NP, Patel MR. Primary lymphoma of the central nervous system: typical and atypical CT and MR imaging appearances. AJR Am J Roentgenol 2001;176(5): 1319-1326.
69. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995; 197(2):525-531.
70. Smyth EG, Stern K. Tumors of the thalamus: a clinicopathological study. Brain 1938;61(4):339-374.
71. Partlow GD, del Carpio-O'Donovan R, Melanson D, Peters TM. Bilateral thalamic glioma: review of eight cases with personality change and mental deterioration. AJNR Am J Neuroradiol 1992;13(4): 1225-1230.
72. Menon G, Nair S, Krishnamoorthy T, et al. Bilateral thalamic glioma: report of four cases and review of literature. J Pediatr Neurosci 2006;1(2):66-69.
73. Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. AJR Am J Roentgenol 1988;151(2): 381-388.
74. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 1995;195(3):721-724.
75. Castillo M, Green C, Kwock L, et al. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. AJNR Am J Neuroradiol 1995;16(1):141-147.